⌘K

Login Start Free

Home/Filings/4/0001127602-25-001839

4//SEC Filing

Lewis Karen 4

Accession 0001127602-25-001839

CIK 0001492422other

View on SEC.gov Company Profile

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 3:29 PM ET

Size

4.5 KB

Accession

0001127602-25-001839

Insider Transaction Report

Form 4

Period: 2025-01-22

Apellis Pharmaceuticals, Inc.APLS

Chief People Officer

Transactions

Sale
Common Stock
2025-01-22$30.43/sh−1,751$53,275→ 70,615 total

Footnotes (1)

[F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 21, 2025.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

Apellis Pharmaceuticals, Inc.

CIK 0001492422

Entity typeother

Related Parties

1

filerCIK 0001814304

Filing Metadata

Form type: 4
Filed: Jan 22, 7:00 PM ET
Accepted: Jan 23, 3:29 PM ET
Size: 4.5 KB

View on SEC.gov